Trial Profile
An open-label, parallel, prospective, randomised, bioavailability study of pradigastat in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Oct 2016
Price :
$35
*
At a glance
- Drugs Pradigastat (Primary)
- Indications Hyperlipoproteinaemia type I
- Focus Pharmacokinetics
- 07 Oct 2016 As per the abstract, this study includes 24 subjects/treatment; so I have added 72 as actual patient number.
- 07 Oct 2016 New trial record